By Giulia Corso|2024-10-18T08:52:00+00:00October 18th, 2024|Extracellular Vesicles, publication|
Newly published article on affinity-based purification of recombinant EVs October 18th, 2024, Vienna, AustriaA recent collaborative work has been published showcasing the
By Giulia Corso|2024-09-26T11:26:20+00:00September 26th, 2024|conferences, EV cell factories, EVscale, Extracellular Vesicles, mesenchymal stromal cells|
We participated to the ASEV and CzeSEV 2024 meeting in Vienna, Austria September 26th, 2024, Vienna, Austria We participated to the
By Giulia Corso|2024-09-26T11:28:45+00:00June 27th, 2024|cell line development, conferences, EV cell factories, extracellular vesicles, organ-on-a-chip|
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at
By Giulia Corso|2024-09-26T11:29:37+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
By Giulia Corso|2024-09-26T11:30:10+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our
By Giulia Corso|2024-09-26T11:30:28+00:00October 27th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, Austria We participated to the first MOVE
By Giulia Corso|2024-09-26T11:30:55+00:00September 19th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the
